Para-Aminobenzoic Acid (Paba) Encyclopedia Article

Para-Aminobenzoic Acid (Paba)

The following sections of this BookRags Literature Study Guide is offprint from Gale's For Students Series: Presenting Analysis, Context, and Criticism on Commonly Studied Works: Introduction, Author Biography, Plot Summary, Characters, Themes, Style, Historical Context, Critical Overview, Criticism and Critical Essays, Media Adaptations, Topics for Further Study, Compare & Contrast, What Do I Read Next?, For Further Study, and Sources.

(c)1998-2002; (c)2002 by Gale. Gale is an imprint of The Gale Group, Inc., a division of Thomson Learning, Inc. Gale and Design and Thomson Learning are trademarks used herein under license.

The following sections, if they exist, are offprint from Beacham's Encyclopedia of Popular Fiction: "Social Concerns", "Thematic Overview", "Techniques", "Literary Precedents", "Key Questions", "Related Titles", "Adaptations", "Related Web Sites". (c)1994-2005, by Walton Beacham.

The following sections, if they exist, are offprint from Beacham's Guide to Literature for Young Adults: "About the Author", "Overview", "Setting", "Literary Qualities", "Social Sensitivity", "Topics for Discussion", "Ideas for Reports and Papers". (c)1994-2005, by Walton Beacham.

All other sections in this Literature Study Guide are owned and copyrighted by BookRags, Inc.

Para-Aminobenzoic Acid (Paba)

One of the most important functions of para-aminobenzoic acid (PABA) is to serve as a nutrient for the intestinal tract's numerous microorganisms. When necessary--because of deficiencies in the diet, for instance--PABA also increases the intestinal synthesis of other B vitamins, particularly of folic acid, of which it is a structural unit.

But PABA has another important distinction. In 1940, the year Richard Kuhn isolated PABA, Kuhn and other researchers soon learned that the new compound appeared to reverse the action of sulfanilamide, one of the early sulfa drugs. When the vitamin and the antibacterial were compared, the two proved to have strikingly similar structures. Surprised but intrigued, Kuhn (and others) speculated that the two compounds might somehow be in competition--a competition that, in this case, PABA was clearly winning.

To help them find answers, researchers began to synthesize compounds that were almost chemically identical to other vitamins. They quickly learned that some of these new synthetics appeared to act as antivitamins: when fed to animals, the synthetics caused a vitamin deficiency state that would, in many cases, be reversed by feeding the original vitamin. More importantly, the discovery of antivitamins made other beneficial advances possible. The synthesis of antivitamin K, for instance, led to the manufacture of dicumarol, an agent that helps prevent the formation of dangerous blood clots. The synthesis of anti-PABA compounds eventually produced sulfa drugs that could effectively treat bacterial infections in most cases, because they had the ability to successfully compete with PABA for positions in a coenzyme necessary for bacterial reproduction.